Total Payments
$8,464
2024 Payments
$1,220
Companies
21
Transactions
591
Medicare Patients
796
Medicare Billing
$93,366
Payment Breakdown by Category
Food & Beverage$8,066 (95.3%)
Education$247.92 (2.9%)
Consulting$150.00 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,066 | 581 | 95.3% |
| Education | $247.92 | 9 | 2.9% |
| Consulting Fee | $150.00 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,381 | 115 | $0 (2024) |
| ABBVIE INC. | $1,247 | 70 | $0 (2024) |
| Alkermes, Inc. | $1,246 | 63 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $816.36 | 59 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $776.93 | 67 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $705.54 | 52 | $0 (2022) |
| ITI, Inc. | $460.21 | 42 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $446.49 | 38 | $0 (2024) |
| Lundbeck LLC | $419.03 | 26 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $207.66 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,220 | 73 | ABBVIE INC. ($413.79) |
| 2023 | $1,445 | 93 | ABBVIE INC. ($405.64) |
| 2022 | $1,502 | 114 | ABBVIE INC. ($256.95) |
| 2021 | $1,304 | 84 | Otsuka America Pharmaceutical, Inc. ($210.21) |
| 2020 | $397.37 | 23 | Sunovion Pharmaceuticals Inc. ($122.32) |
| 2019 | $861.61 | 67 | Otsuka America Pharmaceutical, Inc. ($235.45) |
| 2018 | $737.47 | 63 | Otsuka America Pharmaceutical, Inc. ($149.73) |
| 2017 | $996.34 | 74 | Alkermes, Inc. ($235.19) |
All Payment Transactions
591 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $24.46 | General |
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Neuropsychiatry | ||||||
| 10/02/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $0.60 | General |
| Category: CNS | ||||||
| 09/27/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: CNS | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $0.24 | General |
| Category: Neurology | ||||||
| 09/25/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Neurology | ||||||
| 09/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Neuropsychiatry | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Central Nervous System | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Central Nervous System | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $14.25 | General |
| 08/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Central Nervous System | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 90 | 288 | $28,800 | $15,976 |
| 2022 | 2 | 136 | 359 | $36,588 | $19,462 |
| 2021 | 3 | 211 | 490 | $52,734 | $30,034 |
| 2020 | 4 | 359 | 642 | $67,838 | $27,894 |
Total Patients
796
Total Services
1,779
Medicare Billing
$93,366
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 204 | $20,400 | $10,720 | 52.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 32 | 84 | $8,400 | $5,256 | 62.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 246 | $24,888 | $13,778 | 55.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 58 | 113 | $11,700 | $5,684 | 48.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 115 | 295 | $29,934 | $15,801 | 52.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 182 | $18,500 | $12,301 | 66.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 13 | 13 | $4,300 | $1,932 | 44.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 139 | 383 | $38,648 | $21,502 | 55.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 116 | 140 | $14,290 | $4,158 | 29.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 13 | 13 | $4,300 | $1,245 | 28.9% |
| 99421 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes | Office | 2020 | 91 | 106 | $10,600 | $990.04 | 9.3% |
About Dr. Parimal Purohit, MD
Dr. Parimal Purohit, MD is a Psychiatry healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003894411.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Parimal Purohit, MD has received a total of $8,464 in payments from pharmaceutical and medical device companies, with $1,220 received in 2024. These payments were reported across 591 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($8,066).
As a Medicare-enrolled provider, Purohit has provided services to 796 Medicare beneficiaries, totaling 1,779 services with total Medicare billing of $93,366. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Kansas City, MO
- Active Since 01/05/2006
- Last Updated 07/26/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003894411
Products in Payments
- VRAYLAR (Drug) $1,362
- REXULTI (Drug) $1,163
- ARISTADA (Drug) $732.66
- LATUDA (Drug) $705.54
- ABILIFY MAINTENA (Drug) $530.12
- CAPLYTA (Drug) $522.54
- INVEGA SUSTENNA (Drug) $491.29
- Fanapt (Drug) $320.16
- AUSTEDO (Drug) $282.69
- INGREZZA (Drug) $207.66
- INVEGA TRINZA (Drug) $179.60
- Austedo XR (Drug) $159.85
- TRINTELLIX (Drug) $137.42
- SPRAVATO (Drug) $136.37
- HETLIOZ (Drug) $126.33
- UZEDY (Drug) $125.32
- PERSERIS (Drug) $111.11
- VIVITROL (Drug) $105.58
- Aristada 441 mg (Drug) $88.39
- LYBALVI (Drug) $69.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Kansas City
Dr. Brian Barash, M.d, M.D
Psychiatry — Payments: $825,527
Psychiatry $825,527
Debra Kelsh, M.d, M.D
Psychiatry — Payments: $36,659
Psychiatry $36,659
Mark Cannon, M.d, M.D
Psychiatry — Payments: $18,944
Psychiatry $18,944
Dr. Asim Ulusarac, M.d, M.D
Psychiatry — Payments: $12,464
Psychiatry $12,464
Dr. Tomas Brillantes, M.d, M.D
Psychiatry — Payments: $11,385
Psychiatry $11,385
Christine Trueblood, M.d, M.D
Psychiatry — Payments: $10,633
Psychiatry $10,633